Filing Details
- Accession Number:
- 0001209191-14-057081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-09 18:00:32
- Reporting Period:
- 2014-09-08
- Filing Date:
- 2014-09-09
- Accepted Time:
- 2014-09-09 17:00:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042418 | Hedgepath Pharmaceuticals Inc. | HPPI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612372 | Mark W. Watson | C/O Hedgepath Pharmaceuticals, Inc. 324 S. Hyde Park Avenue, Suite 350 Tampa FL 33606 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-08 | 10,000 | $0.13 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
